Anti-cancer Peptide Inhibitors: Mechanisms and Therapeutic Applications

June 16, 2025 / By

，文章长度约1000单词。

html

Anti-cancer Peptide Inhibitors: Mechanisms and Therapeutic Applications

Cancer remains one of the leading causes of death worldwide, driving the need for innovative therapeutic strategies. Among the emerging approaches, anti-cancer peptide inhibitors have gained significant attention due to their specificity, low toxicity, and ability to target multiple pathways involved in tumor progression. This article explores the mechanisms by which these peptides exert their anti-cancer effects and their potential therapeutic applications.

Understanding Anti-cancer Peptide Inhibitors

Anti-cancer peptide inhibitors are short chains of amino acids designed to interfere with specific molecular processes critical for cancer cell survival, proliferation, and metastasis. Unlike traditional chemotherapy, which often lacks selectivity and causes severe side effects, these peptides can be engineered to target cancer cells with high precision while sparing healthy tissues.

These peptides can be classified into several categories based on their mechanisms of action:

• Cell-penetrating peptides (CPPs): Facilitate the delivery of therapeutic agents into cancer cells.
• Apoptosis-inducing peptides: Trigger programmed cell death in malignant cells.
• Angiogenesis inhibitors: Block the formation of new blood vessels that feed tumors.
• Immune-modulating peptides: Enhance the body’s immune response against cancer cells.

Mechanisms of Action

1. Disruption of Protein-Protein Interactions

Many cancer-related processes rely on protein-protein interactions (PPIs). Anti-cancer peptide inhibitors can mimic or block key domains involved in these interactions, disrupting signaling pathways essential for tumor growth. For example, peptides targeting the p53-MDM2 interaction can reactivate p53, a tumor suppressor protein often inactivated in cancers.

2. Inhibition of Enzymatic Activity

Certain peptides act as competitive inhibitors of enzymes critical for cancer cell metabolism or DNA replication. For instance, peptides targeting histone deacetylases (HDACs) can alter gene expression patterns, leading to cell cycle arrest and apoptosis.

3. Membrane Disruption

Some anti-cancer peptides exhibit direct cytotoxic effects by disrupting the integrity of cancer cell membranes. These peptides often have amphipathic structures that interact with lipid bilayers, forming pores that lead to cell lysis. This mechanism is particularly effective against drug-resistant cancer cells.

4. Immune System Activation

Peptides can also function as immunomodulators by activating dendritic cells, T cells, or natural killer (NK) cells. For example, peptide vaccines derived from tumor-associated antigens can stimulate an immune response against cancer cells.

Therapeutic Applications

1. Targeted Therapy

Anti-cancer peptide inhibitors offer a promising approach for targeted therapy, especially in cancers with specific molecular alterations. For example, peptides targeting HER2/neu overexpression in breast cancer have shown efficacy in preclinical studies.

2. Combination Therapy

These peptides can enhance the effectiveness of conventional treatments like chemotherapy and radiation. By sensitizing cancer cells or protecting normal tissues, they help reduce side effects and improve therapeutic outcomes.

3. Overcoming Drug Resistance

Many cancers develop resistance to traditional drugs. Peptide inhibitors targeting alternative pathways or drug efflux pumps can help overcome this challenge, offering new hope for refractory cancers.

4. Diagnostic Applications

Beyond therapy, some peptides are being developed as diagnostic tools. For instance, tumor-homing peptides conjugated to imaging agents can improve the